Alpha Crest Capital Management LLC Prothena Corp Public LTD CO Transaction History

Alpha Crest Capital Management LLC

  • $0
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$22.73 - $39.98 $348,860 - $613,613
-15,348 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$30.27 - $49.22 $464,583 - $755,428
15,348 New
15,348 $561,000
Q3 2019

Nov 12, 2019
SELL
$6.89 - $10.45 $97,838 - $148,390
-14,200 Closed
0 $0
Q2 2019

Aug 12, 2019
BUY
$8.85 - $12.49 $125,670 - $177,358
14,200 New
14,200 $150,000

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $678M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email